116 - Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response
| Autor: | Sanchez-Garcia, J., Hernandez-Sanchez, J.M., Falantes, J., Benito, R., Medina, A., Lumbreras, E., Hernandez-Mohedo, F., Hermosin, L., Bailen, A., Maria, S., Casaño, J., Calderon, C., Labrador-Mateo, M., Serrano, J., Hernandez-Rivas, J.M. |
|---|---|
| Zdroj: | In Leukemia Research April 2017 55 Supplement 1:S73-S74 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect